Combination therapy with phosphodiesterase type V inhibitors and testosterone

Current Sexual Health Reports

Volumn 5, Issue 3, 2008, Pages 135-140

  Buvat, Jacques ^a   Jaoudé, Gilbert Bou ^b  

^a Centre d'Etude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; EJACULATION; ERECTILE DYSFUNCTION; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIBIDO; MONOTHERAPY; NONHUMAN; PENILE BLOOD VESSEL; PENIS ERECTION; PENIS NOCTURNAL TUMESCENCE; REVIEW; SEXUAL FUNCTION; SMOOTH MUSCLE RELAXATION; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE;

EID: 52649140109     PISSN: 15483584     EISSN: 15483592     Source Type: Journal    
DOI: 10.1007/s11930-008-0024-7     Document Type: Review

References (29)

1. Buvat J, Bou Jaoudé G: Significance of hypogonadism in erectile dysfunction: World J Urol 2006, 24:657-667.
2. Bolona ER, Uraga MV, Haddad RM, et al.: Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007, 82:20-28.
3. Isidori AM, Gianetta E, Gianfrilli D, et al.: Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 2005, 63:381-394.
4. Greenstein A, Mabjeesh NJ, Sofer M, et al.: Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol 2005, 173:530-532.
5. Suzuki N, Sato Y, Hisasue SI, et al.: Effect of testosterone on intracavernous pressure elicited with electrical stimulation of the medial preoptic area and cavernous nerve in male rats. J Androl 2007, 28:218-222.
6. Traish A, Goldstein I, Kim NN: Testosterone and erectile function: from basic research to new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007, 52:54-70.
7. Morelli A, Filippi S, Mancina R, et al.: Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004, 145:2253-2263.
8. Zhang XH, Morelli A, Luconi M, et al.: Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005, 47:409-416.
9. Zhang XH, Filippi S, Morelli A, et al.: Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006, 3:253-264.
10. Vignozzi L, Morelli A, Filippi S, et al.: Testosterone regulates RhoA/ Rho-kinase signaling in two distinct animal models of chemical diabetes. J Sex Med 2007, 4:620-630.
11. Armagan A, Kim NN, Goldstein I, et al.: Dose-response relationship between testosterone an erectile function: evidence for the existence of a critical threshold. J Androl 2006, 27:517-526.
12. Schultheiss D, Badalyan R, Pilatz A, et al.: Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results. World J Urol 2003, 21:320-324.
13. Foresta C, Caretta N, Rossato M, et al.: Role of androgens in erectile function. J Urol 2004, 171:2358-2362.
14. Aversa A, Isidori AM, De Martino MU, et al.: Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 2000, 53:517-522.
15. Aversa A, Isidori AM, Spera G, et al.: Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 2003, 58:632-638.
16. Rochira V, Balestrieri A, Madeo B, et al.: Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, cross-over study of a synergistic role of both testosterone and sildenafil on penile erections. J Androl 2006, 27:165-175.
17. Rosenthal BD, May NR, Metro MJ, et al.: Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology 2006, 67:571-574.
18. Guay AT, Perez JB, Jacobson J, et al.: Efficacy and safety of Sildenafil citrate for treatment of Erectile Dysfunction in a population with associated organic risk factors. J Androl 2001, 22:793-797.
19. Kalinchenko SY, Kozlov GI, Gontcharov NP, et al.: Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003, 6:94-99.
20. Teloken PE, Ohebshalom M, Mohideen N, et al.: Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer. J Urol 2007, 178:2521-2525.
21. Koulikov D, Fridmans A, Chertin B, et al.: Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male? J Urol 2007, 177:2267-2271.
22. Park K, Ku JH, Kim SW, et al.: Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int 2005, 95:366-370.
23. Wespes E, Rammal A, Garbar C: Sildenafil non responders: hemodynamic and morphometric studies. Eur Urol 2005, 48:136-139.
24. Shamloul R, Ghanem H, Fahmy I, et al.: Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study. J Sex Med 2005, 2:559-564.
25. Hwang TI, Chen HE, Tsai TF, et al.: Combined use of androgen and sildenafil for hypogonadal patients non responsive to sildenafil alone. Int J Impot Res 2006, 18:400-404.
26. Yassin AA, Saad F, Diede HE: Testosterone and erectile function in hypogonadal men unresponsive to tadalafil. Results from an open-label uncontrolled study. Andrologia 2006, 38:61-66.
27. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004, 172:658-663.
28. Carosa E, Martini P, Brandetti F, et al.: Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf) 2004, 61:382-386.
29. Greco EA, Pili M, Bruzziches R, et al.: Testosterone:estradiol ratio changes with long-term tadalafil administration: a pilot study. J Sex Med 2006, 3:716-722.